A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age

A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age

This post-marketing surveillance study evaluated the safety of the adjuvanted recombinant zoster vaccine (RZV) in Chinese adults, given the limited country-specific safety data accumulated since the 2019 licensure of RZV in China for adults ≥ 50 years of age (YOA). This descriptive, prospective coho...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinghuo Pang, O’Mareen Spence, Neeraj Parmar, Jing Wang, Tao Zhou, Xiang Guo, Audrey Colliou, Sheela Pradeep Sarang, Mitra Yousefi, Huifeng Yun
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Herpes zoster
adjuvanted recombinant zoster vaccine (RZV)
post-marketing
safety
adverse events
potential immune-mediated diseases
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2439031
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2024.2439031

Similar Items